INFLUENCE OF DRUG-RELEASE RATE ON SYSTEMIC TIMOLOL ABSORPTION FROM POLYMERIC OCULAR INSERTS IN THE PIGMENTED RABBIT

被引:14
作者
LEE, VHL
LI, SY
SASAKI, H
SAETTONE, MF
CHETONI, P
机构
[1] Department of Pharmaceutical Sciences and Drug Targeting Center, University of Southern California, School of Pharmacy, Los Angeles, California
[2] Nagasaki University, School of Pharmaceutical Sciences, Nagasaki
[3] Universita degli Studi di Pisa, Istituto di Chimica Farmaceutica e Tossicologica, Pisa
来源
JOURNAL OF OCULAR PHARMACOLOGY | 1994年 / 10卷 / 02期
关键词
D O I
10.1089/jop.1994.10.421
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
There is an expectation that ocular inserts, regardless of the nature of the polymer, will faithfully reduce systemic drug absorption. This may not necessarily be so, however, since not all polymers would release drug at the same rate and to the same extent. The objective of the present study was to determine how drug release rate from various polymeric ocular inserts may influence systemic timolol absorption in the pigmented rabbit. The inserts tested were made of polyvinyl alcohol (PVA), hydroxypropylcellulose (HPC), or partial ethyl ester of poly(vinyl methyl ether/maleic anhydride) (PVMMA), approximately 89.4% w/w in all cases. Some polyvinyl alcohol inserts contained timolol in salt form with Carbopol 940 (PVA-C940), 8.6% w/w. The time course of timolol in plasma over 6 hr was monitored using reversed phase HPLC. While all inserts reduced the peak timolol concentration in plasma (C(max)), only the PVA and HPC inserts, which released timolol rapidly in vitro, reduced the extent of systemic timolol absorption (AUC). On the other hand, both PVA-C940 and PVMMA inserts, which released timolol relatively slowly in vitro, increased the extent of systemic timolol absorption. Moreover, the time at which peak timolol concentration was achieved in the plasma was much delayed, raising the possibility of delayed timolol absorption until discharge of the presumably viscous and/or mucoadhesive solutions of PVA-C940 and PVMMA inserts into the nasal cavity. It may be concluded that not all polymeric ocular inserts reduce systemic timolol absorption. Whether an insert would do so depends on the interplay of residence time in the conjunctival sac and rate of drug release from the insert.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 15 条
[1]  
Luo A.M., Sasaki H., Lee V.H.L., Ocular drug interactions involving topically applied timolol in pigmented rabbits, Curr. Eve Res., 10, pp. 231-240, (1991)
[2]  
Zimmerman T.J., Karanjit S.K., Kandarakis A.S., Ziegler L.P., Improving the therapeutic index of topically applied ocular drugs, Arch. Ophthalmo1., 102, pp. 551-553, (1984)
[3]  
Ohdo S., Grass G.M., Lee V.H.L., Improving the ocular: systemic ratio of topical timolol by varying the dosing time, Invest. Ophthalmol. Vis. Sci., 32, pp. 2790-2798, (1991)
[4]  
Chang S.C., Bundgaard H., Burr A., Lee V.H.L., Low dose 0-butyryl timolol improves the therapeutic index of timolol in the pigmented rabbit, Invest. Ophthalmol. Vis. Sci., 29, pp. 626-629, (1988)
[5]  
Kyyronen K., Urtti A., Improved ocular:systemic absorption ratio of timolol by viscous vehicle and phenylephrine, Invest. Ophthalmol. Vis. Sci., 31, pp. 1827-1833, (1990)
[6]  
Chang S.C., Chien D.S., Bundgaard H., Lee V.H.L., Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol, Exp. Eve Res., 46, pp. 59-69, (1988)
[7]  
Podder S.K., Moy K.C., Lee V.H.L., Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition, Exp. Eve Res., 54, pp. 747-757, (1992)
[8]  
Chang S.C., Lee V.H.L., Nasal and conjunctival contributions to the systemic absorbtion of topical timolol in the pigmented rabbit: Implications in the design of strategies to maximize the ratio of ocular to systemic absorption, J. Ocular Pharmacol., 3, pp. 159-169, (1987)
[9]  
Peppas N.A., Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv., 60, pp. 110-111, (1985)
[10]  
Gibaldi M., Perrier D., Pharmacokinetics, pp. 1-494, (1982)